Zantac
NDC 52565-102
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
Zantac is a NDA-approved product labeled by Teligent Pharma, Inc.. Ranitidine is used to treat ulcers of the stomach and intestines and prevent them from coming back after they have healed. It is supplied as a yellow product. This product entry covers the primary NDC 52565-102 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
52565-102
Proprietary Name:
Zantac
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Code Navigator:
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
52565
Product Label ID:
FDA Application Number: [6]
NDA019090
Marketing Category: [8]
NDA - A product marketed under an approved New Drug Application.
Marketing Timeline
Start Marketing Date: [9]
08-23-2017
Listing Expiration Date: [11]
12-31-2021
Exclude Flag: [12]
I
Product Characteristics
Color(s):
YELLOW (C48330 - COLORLESS TO YELLOW)
Code Structure Chart
Product Details
What is NDC 52565-102?
The NDC code 52565-102 is assigned by the FDA to the product Zantac. This pharmaceutical product is labeled by Teligent Pharma, Inc. and is currently categorized as listed product. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 52565-102-05. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are the uses of this product?
Ranitidine is used to treat ulcers of the stomach and intestines and prevent them from coming back after they have healed. This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Ranitidine belongs to a class of drugs known as H2 blockers. This form of ranitidine is given by injection and is used for short-term treatment of these conditions when you cannot take this medication by mouth. Your doctor should switch you to taking this medication by mouth when possible. This drug has been withdrawn from the US market due to problems with safety. A possible cancer-causing impurity has been found in some ranitidine products.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RANITIDINE HYDROCHLORIDE (UNII: BK76465IHM)
- RANITIDINE (UNII: 884KT10YB7) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- PHENOL (UNII: 339NCG44TV)
- POTASSIUM PHOSPHATE, MONOBASIC (UNII: 4J9FJ0HL51)
- SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)
What is the NDC to RxNorm Crosswalk for this product?
RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
- RxCUI: 104084 - Zantac 25 MG/ML Injectable Solution
- RxCUI: 104084 - ranitidine 25 MG/ML Injectable Solution [Zantac]
- RxCUI: 1859553 - 2 ML ranitidine 25 MG/ML Injection
- RxCUI: 1859553 - ranitidine (as ranitidine HCl) 50 MG per 2 ML Injection
- RxCUI: 1859554 - Zantac 50 MG in 2 ML Injection
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".
